Compare AstraZeneca plc (AZN) vs eBay Inc (EBAY) Price & Performance

AstraZeneca (AZN) trades at $169.47, down 1.25% amid recent volatility following a Phase III trial failure for Wainua. The stock shows bearish technical signals with key support at $168 and resistance at $170. Fundamentally, the company reported strong 2025 results with revenue of $58.74B and net income of $10.23B, though a recent $1.5B licensing deal for a lung cancer drug highlights ongoing pipeline investments. Analyst sentiment is mixed with 47.5% buy ratings but recent downgrades from firms like HSBC citing trial setbacks.

The outlook balances robust financials against pipeline execution risks. Revenue growth and high margins support valuation, but the Wainua failure raises concerns about future catalysts. Investors should weigh the company's strong cash flow and market position against clinical trial volatility and potential legal investigations. Near-term price action may hinge on Q2 2026 earnings due July 27, 2026.

EBAY trades at $115.09, down 1.8% today, amid a bullish technical setup with strong moving average signals and key support at $114. The company shows robust profitability with a 71.79% gross margin and consistent earnings beats, while navigating a potential acquisition by GameStop. Revenue growth is steady, reaching $11.10B in 2025, though net cash flow turned negative.

Outlook remains mixed: strong fundamentals and bullish analyst sentiment (46% buy ratings) support upside, but risks include the uncertain GameStop takeover bid and competitive pressures. The stock trades above the $107.82 consensus target, suggesting limited near-term gains unless earnings surprise again.